3 years ago

Effective degradation of carbamazepine using a novel electro-peroxone process involving simultaneous electrochemical generation of ozone and hydrogen peroxide

Effective degradation of carbamazepine using a novel electro-peroxone process involving simultaneous electrochemical generation of ozone and hydrogen peroxide
An advanced electrochemical oxidation process (electro-peroxone) involving a dual electrode system was developed to degrade recalcitrant carbamazepine (CBZ). During this electro-peroxone (E-peroxone) process, ozone was electrochemically produced by anodic oxidation of water in a membrane electrode assembly (MEA) cell and H2O2 was simultaneously generated by the sparged O2 using a carbon-polytetrafluorethylene (C-PTFE) cathode. The O3 and H2O2 electrogenerated in situ synergistically produce hydroxyl radicals (OH), which are much more easily oxidized than O3. As a result, the removal efficiencies of CBZ and its TOC reached 99.8% and 97.6% after 15min and 90min of E-peroxone treatment, respectively, these figures remaining stable after multiple tests. The E-peroxone process is therefore a promising and effective method for degrading ozone-refractory organic contaminants in wastewater.

Publisher URL: www.sciencedirect.com/science

DOI: S1388248117303041

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.